Press release by OneTouch on 12 September 2017
New OneTouch Reveal® Mobile App Empowers People with Diabetes to Manage their Blood Sugar and Easily Connects them with their Diabetes Care Support Network
Easy-to-use interconnected diabetes management system changes the way patients see their blood sugar readings and enables healthcare professionals, family, and friends to help them manage their condition
The new OneTouch Reveal® mobile app is now available in the UK and Ireland. It includes innovative, user-inspired features including blood sugar and activity timelines transformed into quick visual snapshots which allow people with diabetes to see their results, identify trends and get on with their daily life.
The new version of the OneTouch Reveal® mobile app has been designed to help patient engagement. It has an easy to use interface that changes the way patients see their blood sugar and manage their diabetes. In addition to the timeline and visual logbook, new features include a fingerprint login, an events newsfeed featuring relevant articles, a reminder function, averages for 14-, 30-, or 90- day time periods, and a break out of pre- and post-meal tagged results. The OneTouch Reveal® mobile app also uses ColorSure™ technology, which highlights patterns that show users a bigger picture.
Dr Iain Cranston, Consultant Physician at Portsmouth Hospitals NHS Trust said, “It is important that people with diabetes who test their blood sugar levels regularly are able to utilise the information from such tests to adjust therapies which may help with better overall control. Modern meters and apps (such as OneTouch Reveal®) which allow patients to easily assess patterns are thus an important part of this progressive process of improvement.”
The OneTouch Reveal® mobile app is the central component of the OneTouch® circle of support that connects patients to resources beyond devices. The OneTouch Reveal® mobile app seamlessly syncs with the OneTouch Verio Flex® blood glucose monitoring (BGM) system with built-in Bluetooth® Smart Technology. This connectivity enables users to see their blood glucose readings on the mobile app on their smart device and on their computer through the OneTouch Reveal® web app, and also makes it easier than ever for patients to share their data with their healthcare teams so that the teams can see their progress.
Chris Aldred, aka The Grumpy Pumper has been trying out the OneTouch Reveal® mobile app. He said “I’m not one for logging my data or messing about with cables for uploading it, I’ve got a life to live and it’s not going to be slowed down by my Diabetes. So at the times I do want to log my data, such as annual review time, being able to Bluetooth it across to the app is really useful.”
Martin Lambert, Head of Marketing UK&I, Johnson and Johnson Diabetes Care Companies (makers of OneTouch® products) said “We are delighted to launch the new OneTouch Reveal® mobile app and digital platform. We have designed the new interface with engaging social networking apps in mind, to appeal both to people with diabetes who are new to digital diabetes apps, as well as those who are more familiar with their use. Enhanced connectivity and the new user experience to help people with diabetes to quickly see and check their results, allowing them to make meaningful decisions and take an active role in their diabetes management.”
With more than 312,000 total downloads and 34 million plus blood glucose readings, the OneTouch Reveal® mobile app is one of the top downloaded diabetes apps globally. In a clinical study, eight out of 10 people who had used the OneTouch Reveal® mobile app agreed that it helped them to better manage their blood glucose.
About Johnson & Johnson Diabetes Care Companies (JJDCC)
With a shared vision of creating a world without limits for people with diabetes, the Johnson & Johnson Diabetes Care Companies are a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of innovative insulin delivery systems; Calibra Medical, Inc. developer of OneTouch Via™ on-demand insulin delivery; and the Johnson & Johnson Diabetes Institute, LLC, a global initiative to improve care and better outcomes worldwide through education and training programs. In the U.S., LifeScan, Inc. is the leading blood glucose monitoring company and OneTouch® brand products are recommended by more endocrinologists and primary care physicians than any other brand. Globally, more than 20 million people depend on OneTouch® brand products to help them manage their diabetes. For more information, visit: www.myOneTouch.co.uk